Literature DB >> 24005769

Three cases of linear IgA/IgG bullous dermatosis showing IgA and IgG reactivity with multiple antigens, particularly laminin-332.

Masanobu Sakaguchi1, Toshinori Bito, Yoshiko Oda, Ayuko Kikusawa, Chikako Nishigori, Takichi Munetsugu, Hiroo Yokozeki, Yuri Itotani, Toshiyuki Niguma, Daisuke Tsuruta, Chiharu Tateishi, Norito Ishii, Hiroshi Koga, Takashi Hashimoto.   

Abstract

IMPORTANCE: Linear IgA/IgG bullous dermatosis (LAGBD) is a relatively rare autoimmune bullous disease characterized by both IgA and IgG antibodies to epidermal basement membrane zone. The heterogeneity and pathogenesis of the LAGBD autoantigens have not been fully elucidated. OBSERVATIONS: We report 3 Japanese cases of LAGBD (ages 81, 88, and 64 years; 1 woman and 2 men). The patients showed bullous and erosive lesions on the trunk and extremities with minimal mucosal lesions. Histopathological analysis revealed a subepidermal blister with neutrophilic infiltration with eosinophils in 2 cases. Direct and indirect immunofluorescence studies disclosed IgG and IgA antibasement membrane zone antibodies. In immunoblot analyses of various antigen sources, all cases showed IgG and IgA antibodies to various subunits of laminin-332, in addition to IgG and IgA reactivity with type VII collagen, laminin-γ1, and BP230 and BP180 recombinant proteins. CONCLUSIONS AND RELEVANCE: Our studies revealed that the 3 LAGBD cases showed prominent IgG and IgA reactivity with laminin-332, which was only rarely reported. In addition, all cases showed IgG and IgA reactivity with other multiple antigens, indicating the role of epitope-spreading mechanisms initiated from laminin-332. The significance of IgA antibodies to laminin-332 should be studied in larger cohorts of both LAGBD and linear IgA bullous dermatosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005769     DOI: 10.1001/jamadermatol.2013.5691

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  6 in total

1.  Autoantibodies Against Multiple Epitopes in Bp180 and Laminin Gamma-1 in Subepidermal Blistering Skin Disease Associated with Psoriatic Erythroderma.

Authors:  Haruna Goto-Hamano; Keiko Ito; Kumiko Sakamoto-Kimura; Tadashi Terui; Bungo Ohyama; Takashi Hashimoto; Hiroyuki Hara
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

2.  Linear IgA bullous dermatosis successfully treated with omalizumab: A case report.

Authors:  Nadine S Maalouf; Dominique Hanna
Journal:  JAAD Case Rep       Date:  2019-10-24

3.  Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab.

Authors:  Dmitry Nedosekin; Kelsey Derrick Wilson; Katelynn Campbell; Sara Shalin; Henry K Wong
Journal:  JAAD Case Rep       Date:  2021-01-11

4.  Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report.

Authors:  Morten Bahrt Haulrig; Signe Ledou Nielsen; Jesper Elberling; Lone Skov
Journal:  Clin Case Rep       Date:  2022-03-08

Review 5.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

Review 6.  Antigen recognition in the pathogenesis of immunoglobulin A-related autoimmune bullous diseases.

Authors:  Zhiliang Li; Ke Jing; Suo Li; Suying Feng
Journal:  Postepy Dermatol Alergol       Date:  2018-08-21       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.